Selection criteria for reduction hepatectomy in multiple advanced hepatocellular carcinoma.
Few studies have compared the prognostic impact of reduction hepatectomy (RH) for advanced hepatocellular carcinoma (HCC) with that of non-surgical treatment or curative hepatectomy. The treatment outcome of 30 RH patients was compared to that of two control groups: control group A, including 71 patients who underwent curative hepatectomy; control group B, including 106 patients who did not receive definitive local therapy or best supportive care. In patients with tumor extension in >50% of the liver, 1-year survival rates for patients according to treatment (RH, control A and B) were 50%, 90% and 11% and 3-year survival rates were 42%, 60% and 0%, respectively. There was no significant difference between RH and control A, but there was a significant difference between RH and control B. RH could be recommended to patients with multiple advanced HCC extending to >50% of the whole liver.